Ledger.Open graph →
SEC Form D · filed July 10, 2020

Vor Biopharma Inc

Offering
$110.1M
Sold
$110.1M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Nathan Jorgensen · Newton, MAExecAmy Mendel · Cambridge, MAExecKush Parmar · Boston, MADirectorJoshua Resnick · Needham, MADirectorSven Lundberg · Cambridge, MADirectorRobert Ang · Cambridge, MAExec · DirectorNathan Jorgensen · Cambridge, MAExecAmy Mendel · Cambridge, MAExecKush Parmar · San Francisco, CADirectorJoshua Resnick · Los Angeles, CADirectorSven Lundberg · Cambridge, MADirectorRobert Ang · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗